Table 1.
Participant | Age at Implant | Etiology | Age at Onset of HL (P/B) | Age HA Use Began (P/B) | Age HA Use Ended (P) | Duration SPHL CI Ear (P) | Hearing Aid (B) |
---|---|---|---|---|---|---|---|
P1 | 45 | Unknown | 25 / 25 | 25 / 25 | 45 | 1 | Widex Diva 19 |
P2 | 28 | Meniere's | 19 / 19 | 22 / 22 | 24 | 1.5 | Beltone LINQ |
P3 | 59 | Familial | 20 / 20 | 23 / 28 | 56 | 10 | Phonak Naida V SP |
P4 | 28 | Unknown | 3 / 3 | Never / 3 | n/a | 25 | Unitron Power |
P5 | 28 | Unknown/EVA | 5* / 23 | Never / 28 | n/a | 23 | Starkey S Series |
P6 | 26 | Meningitis | 7 months | Never / 1 | n/a | 25.5 | Widex Inteo 19 |
P7 | 77 | Unknown | 37 / 57 | Never / 67 | n/a | 40 | Widex Mind 440 |
P8 | 82 | Familial/Noise | 62 / 62 | 63 / 77 | 77 | 6 | Starkey S Series |
P9 | 80 | Meniere's/Noise | 47 / 25 | Never / 63 | n/a | 34 | Phonak Eleva |
P10 | 76 | Unknown | 61 / 61 | 69 / 75 | 72 | 6 | Starkey S Series |
Possibly congenital
Note: EVA = enlarged vestibular aqueduct; HL = hearing loss; P = poorer hearing ear; B = better hearing ear; HA = hearing aid; SPHL = severe-to-profound hearing loss; CI = cochlear implant